If you are a dog lover, you might be interested in a new drug that could extend the life of your furry friend. The drug, called CaniVita, is currently pending approval with the Food and Drug Administration (FDA) and claims to slow down the aging process in dogs.
According to the company behind CaniVita, the drug works by activating a gene that protects the cells from oxidative stress and inflammation, two major factors that contribute to aging and age-related diseases. The drug also boosts the immune system and enhances the metabolism of dogs.
The company says that CaniVita can extend the lifespan of dogs by up to 25%, depending on the breed and size. That means that a dog that would normally live for 10 years could live for 12.5 years with CaniVita. The drug is administered as a daily pill that can be mixed with food or given as a treat.
Tekedia Mini-MBA edition 14 (June 3 – Sept 2, 2024) begins registrations; get massive discounts with early registration here.
Tekedia AI in Business Masterclass opens registrations here.
Join Tekedia Capital Syndicate and invest in Africa’s finest startups here.
The company has conducted several clinical trials with more than 500 dogs of different breeds and ages and claims that the results are promising and consistent. The company also says that the drug is safe and has no significant side effects.
However, not everyone is convinced by CaniVita. Some experts have raised concerns about the ethical and social implications of extending the life of dogs. They argue that prolonging the life of dogs could lead to overpopulation, environmental issues, and animal welfare problems. They also question the quality of life of dogs that are kept alive beyond their natural lifespan.
Additionally, some critics have pointed out that CaniVita is not yet approved by the FDA, and that the company has not published its data in peer-reviewed journals. They warn that the drug might not be as effective or safe as the company claims, and that there might be unknown risks or complications.
Therefore, if you are considering giving CaniVita to your dog, you should consult with your veterinarian first and weigh the pros and cons carefully. You should also keep in mind that CaniVita is not a miracle cure, and that your dog will still need proper care, nutrition, exercise, and love to live a happy and healthy life.
The drug, called Rejuvenate, is designed to slow down the aging process in dogs by targeting the cellular mechanisms that cause deterioration and disease. Rejuvenate is based on the research of Sam Altman, a billionaire entrepreneur and investor who is also the founder of OpenAI, a research organization dedicated to creating artificial intelligence that can benefit humanity.
Altman believes that aging is not inevitable, but rather a biological problem that can be solved with science and technology. He has been taking Rejuvenate himself for the past two years, and claims that he feels younger, stronger, and more energetic than ever. He also says that he expects to live at least ten years longer than the average lifespan.
Rejuvenate is not yet available for public use, but it has been undergoing clinical trials with dogs of different breeds and ages. The results have been promising so far, showing that rejuvenate can improve the health and vitality of dogs, as well as extend their lifespan by up to 25%. Some of the benefits reported by the owners of the dogs participating in the trials include:
Improved mobility and agility.
Reduced inflammation and pain.
Enhanced cognitive function and memory.
Increased appetite and metabolism.
Better coat quality and appearance.
Lower risk of cancer and other age-related diseases.
Rejuvenate is expected to receive FDA approval for dogs by the end of next year and will be sold as a monthly injection that can be administered by a veterinarian or at home. The cost of Rejuvenate is not yet known, but Altman says that he wants to make it affordable and accessible for everyone who loves their dogs.
He also hopes that Rejuvenate will pave the way for developing a similar drug for humans, which could potentially revolutionize the field of anti-aging medicine and extend the human lifespan by decades.
Rejuvenate is not just a drug, but a vision for a better future for our canine companions and ourselves. As Altman says, “We love our dogs as much as we love ourselves, and we want them to live as long as we do. With Rejuvenate, we can make that dream a reality.”